DRUG · COUNSELLING NOTES
Teplizumab
TZIELD
Updated
New prescription
indication: _____. IV infusion x14 days in clinic; warned on allergies; serious/common AEs: cytokine release (fever), low lymphocytes, rash; non-pharm: glucose monitoring, infection precautions.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV infusion x14 days in clinic; warned on allergies; serious/common AEs: cytokine release (fever), low lymphocytes, rash; non-pharm: glucose monitoring, infection precautions.